LuSeed Vascular

Vascular Remodeling Device

Health Tech & Life Sciences
Active
Seed Petah Tikva Founded 2017
Total raised
$6.5M
Last: Seed 2024-10
Stage
Seed
Founded
2017
Headcount
16
HQ
Petah Tikva
Sector
Health Tech & Life Sciences

About

LuSeed Vascular is a pioneering medical technology startup that focuses on advancing neurovascular innovation.

LuSeed’s ARC is a first-in-class, minimally invasive device for treating both Bifurcation and Sidewall brain aneurysms simply and safely. The device is designed for full compatibility with robotic systems. Its mission is to provide a standard method of care, easily implemented by neuro radiologists at various experience levels, to improve both acute and long-term patient outcomes, mitigate potential complications, and optimize hospitals’ operational and financial burdens.

LuSeed has currently began its clinical phase, with so far highly promising results.

Funding history · 3 rounds · $6.5M total

2024-10
Seed Undisclosed
2023-01
Series A $3.5M
2020-01
Seed $3.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Products
Business model
B2B

Highlights

1 PatentsVerified

Tags

therapeutic-devicesneurosurgeryradiologymedical-devicesminimally-invasivevascularmedical-technologiesneurovascularmedical-productsstrokebrain-disorder